Softgel Capsules Market Size, Share, Growth, and Industry Analysis, By Type (Gelatin Type, Non-animal Type), By Application (Health Supplements, Pharmaceutical, Others), Regional Insights and Forecast From 2026 To 2035

Softgel Capsules Market Overview

The global softgel capsules market size is projected to reach USD 5226 Million in 2026 and is expected to grow further to USD 7982.69 Million by 2035, registering a CAGR of 4.8% during the forecast period from 2026 to 2035. The market growth is supported by increasing adoption of advanced oral dosage formats across pharmaceutical and nutraceutical industries. Rising demand for vitamins, dietary supplements, omega-based formulations, and improved drug delivery solutions is encouraging manufacturers to expand production capabilities and invest in innovative encapsulation technologies. The growing preference for convenient, easy-to-consume healthcare products continues to strengthen market opportunities globally.

The softgel capsules market is evolving as pharmaceutical, nutraceutical, and healthcare manufacturers increasingly prefer advanced oral delivery formats for liquid, oil-based, and poorly soluble ingredients. These capsules provide advantages such as improved ingredient protection, accurate dosage administration, better swallowing experience, and enhanced consumer convenience. The growing use of vitamins, minerals, omega formulations, herbal extracts, and specialty medicines is strengthening demand across healthcare industries. Manufacturers are focusing on advanced encapsulation processes, sustainable shell materials, and customized formulations to meet changing consumer preferences. Gelatin-based and plant-derived capsule technologies are both gaining attention as companies expand product portfolios across pharmaceutical and wellness applications.

The USA market is supported by strong demand from pharmaceutical companies, dietary supplement brands, and preventive healthcare consumers. The country has a well-established ecosystem for contract manufacturing, research, and development of advanced oral dosage products. Consumers in the USA increasingly prefer convenient supplement formats containing vitamins, minerals, omega-3 oils, and botanical ingredients. Pharmaceutical manufacturers are adopting capsule-based delivery systems for improving bioavailability and patient compliance. The increasing preference for vegetarian and clean-label products is encouraging companies to develop alternative shell materials. Advanced manufacturing facilities, strong regulatory standards, and high adoption of wellness products continue to support market expansion across the USA healthcare sector.

Key Findings

• Market Size and Forecast: Global softgel capsules market reaches USD 5226 Million in 2026 and USD 7982.69 Million by 2035 with CAGR 4.8%.

• Type Leadership: Gelatin Type dominates with 63% share due to proven stability, manufacturing efficiency, and broad pharmaceutical acceptance.

• Application Leadership: Pharmaceutical applications lead with 60% share supported by advanced drug delivery and improved ingredient absorption requirements.

• Key Company Landscape: Catalent and Aenova lead through manufacturing scale, formulation expertise, innovation, and global healthcare partnerships.

• Fastest Growing Region: North America leads with 33% share due to supplement demand, pharmaceutical innovation, and healthcare infrastructure.

• Key Trends: Plant-based shells, customized formulations, and advanced encapsulation technologies are driving innovation with 37% non-animal adoption.

Softgel Capsules Market Latest Trends

The softgel capsules market is experiencing transformation due to increasing demand for convenient healthcare products and advanced formulation technologies. Manufacturers are focusing on improving capsule performance through innovative shell materials, better sealing technologies, and enhanced ingredient compatibility. The rising popularity of plant-based alternatives is encouraging companies to introduce vegetarian capsule solutions using materials such as hydroxypropyl methylcellulose and other polymers. Pharmaceutical companies are increasingly adopting advanced delivery formats for ingredients with low water solubility because these systems can improve formulation flexibility and consumer acceptance. The pharmaceutical segment represents 60% share in this report due to increasing usage in prescription medicines, over-the-counter products, and specialty formulations.

Nutraceutical demand is also influencing product development, particularly for omega oils, vitamins, minerals, herbal extracts, and wellness supplements. Companies are investing in personalized nutrition products and targeted formulations designed for immunity, beauty, healthy aging, and sports performance. Automation in manufacturing, improved quality-control systems, and sustainable production practices are becoming important competitive factors. Manufacturers are developing smaller capsule sizes, customized shapes, and specialized release technologies to improve consumer experience. Growing demand for clean-label healthcare products and increasing focus on preventive wellness continue to create opportunities for innovation across pharmaceutical and supplement industries.

Softgel Capsules Market Dynamics

DRIVER

"Rising demand for convenient pharmaceutical and nutritional delivery formats."

Growing consumer preference for easy-to-use healthcare products is a major factor supporting market expansion. Soft capsule formats provide advantages including precise dosage, improved swallowing convenience, and efficient delivery of liquid-based ingredients. Pharmaceutical companies increasingly use these formats for medicines containing oils, vitamins, and active ingredients requiring enhanced stability. The health supplement sector is also contributing significantly because consumers are adopting daily wellness products for preventive healthcare. The pharmaceutical application segment holds 60% share due to increasing utilization in prescription and non-prescription products. Growing awareness about nutritional deficiencies, chronic health management, and personalized wellness solutions is encouraging manufacturers to expand production capabilities and introduce specialized formulations.

RESTRAINT

"Complex production processes and raw material challenges."

The market faces limitations due to advanced manufacturing requirements, strict quality standards, and dependence on specialized raw materials. Production requires controlled environments, advanced encapsulation equipment, and technical expertise to maintain product consistency. Gelatin sourcing can create challenges because manufacturers must meet quality, safety, and regulatory requirements. At the same time, companies developing plant-based alternatives face difficulties related to formulation stability, scalability, and production optimization. Regulatory differences between countries also increase operational complexity for global manufacturers. Maintaining consistent quality while managing production costs remains a significant challenge. Companies must continuously improve manufacturing technologies and supply chain strategies to overcome these barriers and maintain competitiveness.

OPPORTUNITY

"Expansion of plant-based and customized healthcare formulations."

Increasing consumer interest in vegetarian, vegan, and clean-label products is creating new opportunities for manufacturers developing alternative shell technologies. Non-animal capsule solutions are gaining attention among supplement users seeking sustainable and ethical product options. The non-animal segment represents 37% share in this report, highlighting growing acceptance of alternative materials. Personalized nutrition, beauty supplements, sports products, and healthy aging formulations provide additional opportunities for innovation. Manufacturers are also exploring customized delivery systems that combine multiple active ingredients into convenient dosage formats. Expansion of healthcare access in emerging markets and increasing digital distribution channels further support opportunities for companies developing differentiated products.

CHALLENGE

"Maintaining regulatory compliance and product differentiation."

Manufacturers face challenges related to strict regulatory requirements, quality assurance, and increasing market competition. Pharmaceutical and supplement companies must ensure accurate formulation, stability, safety, and proper labeling across different regions. Rising consumer expectations for sustainable ingredients and transparent sourcing require manufacturers to redesign existing products and production processes. Competition among global and regional producers is increasing as companies invest in advanced technologies and expanded manufacturing capacity. Maintaining cost efficiency while developing innovative formulations remains difficult. Businesses must balance research investment, operational efficiency, and changing consumer preferences to remain competitive in the evolving healthcare delivery industry.

Softgel Capsules Market Segmentation

The market segmentation is based on product type and application areas, including gelatin type, non-animal type, health supplements, pharmaceutical products, and other specialized uses. Gelatin-based capsules continue to maintain strong demand because of their established manufacturing processes, flexibility, and compatibility with different formulations. At the same time, plant-based alternatives are gaining attention due to increasing consumer interest in vegan and sustainable healthcare products. Pharmaceutical applications represent a major usage area because these delivery formats help improve ingredient stability and consumer convenience. The changing preferences of healthcare companies and supplement manufacturers are encouraging innovation across capsule materials, formulation methods, and targeted delivery solutions.

By Type

Based on Type the global market can be categorized in to Gelatin Type and Non-animal Type.

• Gelatin Type: Gelatin type capsules represent the largest segment due to their long-standing acceptance in pharmaceutical and nutritional product manufacturing. This segment accounts for 63% market share, supported by cost efficiency, reliable availability, excellent sealing properties, and compatibility with liquid and oil-based ingredients. Gelatin materials provide flexibility, transparency, and strong mechanical performance, making them suitable for vitamins, supplements, prescription medicines, and specialty formulations. Pharmaceutical companies continue using gelatin-based solutions because of established production systems and extensive regulatory experience. Manufacturers are improving gelatin quality through advanced purification methods and specialized grades to enhance stability and performance. Despite increasing demand for plant-based alternatives, gelatin remains a preferred material because of its proven manufacturing advantages and broad industry acceptance. The segment continues to benefit from large-scale production capabilities, established supply chains, and strong demand from healthcare companies seeking dependable dosage formats.

• Non-animal Type: Non-animal type capsules are gaining importance as consumers increasingly seek vegetarian, vegan, and clean-label healthcare products. This segment holds 37% market share and is supported by rising awareness about sustainable ingredients and ethical sourcing practices. These capsules are developed using plant-derived materials such as hydroxypropyl methylcellulose, carrageenan, and other polymers that provide alternatives to traditional animal-derived materials. The growing demand for natural supplements, premium nutrition products, and sustainable healthcare solutions is encouraging manufacturers to expand their plant-based portfolios. Companies are investing in improved shell technologies to achieve better stability, transparency, and compatibility with different active ingredients. Non-animal alternatives are especially gaining attention among supplement brands targeting health-conscious consumers. The segment also benefits from increasing product launches focused on immunity, beauty nutrition, sports wellness, and personalized healthcare applications. Continued innovation in material science is expected to strengthen adoption of these alternatives across global markets.

By Application

Based on Application the global market can be categorized in to Health Supplements, Pharmaceutical, and Others.

• Health Supplements: Health supplements represent an important application segment due to increasing consumer focus on preventive healthcare, nutrition management, and wellness lifestyles. This segment accounts for 25% market share and includes products such as vitamins, minerals, omega oils, herbal extracts, and specialty nutritional formulations. Capsule-based supplement formats are preferred because they provide accurate dosage, convenient consumption, and effective protection for sensitive ingredients. Growing awareness regarding immunity support, healthy aging, cardiovascular wellness, and beauty nutrition is encouraging companies to introduce innovative formulations. Supplement manufacturers are developing customized products with multiple active ingredients to address specific consumer needs. The expansion of online health product channels and increasing availability of premium nutritional products are further supporting demand. Companies are also adopting advanced encapsulation technologies to improve ingredient stability and consumer experience. The increasing preference for easy-to-consume wellness products continues to create opportunities for manufacturers operating in the health supplement category.

• Pharmaceutical: Pharmaceutical applications dominate the market due to increasing adoption of advanced oral dosage formats for prescription medicines, over-the-counter products, and specialty treatments. This segment holds 60% market share, supported by the ability of these capsules to improve absorption, protect sensitive ingredients, and deliver liquid or semi-solid formulations effectively. Pharmaceutical companies use these systems for ingredients that require enhanced bioavailability and improved patient convenience. The format is widely preferred for medicines containing oils, active pharmaceutical ingredients, and compounds with formulation challenges. Growing demand for patient-friendly medication options is encouraging manufacturers to convert certain formulations into capsule-based delivery systems. Contract manufacturing companies are also expanding production capabilities to support pharmaceutical brands seeking specialized manufacturing expertise. Continuous research in drug delivery technology, formulation optimization, and controlled-release solutions is strengthening pharmaceutical adoption. The segment remains a key contributor because healthcare companies prioritize efficient, reliable, and consumer-friendly medication formats.

• Others: Other applications contribute to market development through usage in cosmetics, personal care supplements, specialty nutrition, and emerging wellness categories. This segment accounts for 15% market share and includes innovative formulations designed for targeted consumer requirements. Companies are exploring capsule formats for beauty supplements, functional ingredients, and specialized healthcare products requiring improved stability and convenience. Demand from premium wellness categories is encouraging manufacturers to develop differentiated products with unique ingredient combinations. Advancements in formulation technology are allowing companies to incorporate sensitive oils, botanical extracts, and specialty compounds into convenient delivery formats. The segment is supported by increasing consumer interest in multifunctional products that combine nutritional and lifestyle benefits. Manufacturers are also focusing on sustainable materials and customized designs to attract niche consumer groups. Growing innovation beyond traditional pharmaceutical and supplement uses continues to create additional opportunities for industry participants.

Softgel Capsules Market Regional Outlook

• North America

North America accounts for 33% of the global market, maintaining leadership through extensive pharmaceutical research, established contract manufacturing infrastructure, and widespread dietary supplement consumption. The United States represents the principal regional demand center, with manufacturers developing lipid-based medicines, vitamins, omega formulations, botanical products, and specialty nutritional supplements. Strong consumer familiarity with capsule-based delivery supports repeat purchasing across pharmacies, specialist retailers, and digital commerce channels. Regional manufacturers increasingly invest in smaller dosage formats, improved sealing technologies, controlled-release formulations, and alternative shell materials. Contract development organizations also provide formulation, clinical supply, commercial production, packaging, and lifecycle management services for pharmaceutical brands. The regional competitive environment encourages continuous innovation in bioavailability enhancement and ingredient protection. Growing interest in personalized nutrition, healthy aging, sports wellness, and preventive healthcare further supports product diversification. North America's established regulatory environment and sophisticated manufacturing ecosystem reinforce its position as the largest regional market.

• Europe

Europe represents 27% of global demand, supported by advanced pharmaceutical production, strong contract manufacturing capabilities, established nutraceutical industries, and rigorous quality requirements. Germany remains an important production center, while the United Kingdom, France, Italy, and Spain contribute through pharmaceutical development and consumer health product manufacturing. European producers increasingly offer both gelatin and plant-derived formulations to address changing dietary preferences and ingredient-origin requirements. Regional consumers demonstrate strong interest in vitamins, omega products, botanical ingredients, healthy-aging formulations, and preventive wellness solutions. Manufacturers are consequently developing clean-label products, smaller dosage formats, and specialized delivery technologies. Regulatory attention to raw material traceability and manufacturing quality encourages investment in modern processing facilities and quality-control systems. Partnerships between ingredient suppliers, contract manufacturers, pharmaceutical businesses, and supplement brands are supporting faster commercialization. Demand is additionally strengthened by aging populations and the increasing preference for convenient oral dosage forms that simplify routine supplementation and medication administration.

• Asia Pacific

Asia Pacific holds 25% of the market and represents an important center for production capacity expansion, pharmaceutical outsourcing, and consumer healthcare development. China, India, Japan, South Korea, and Australia support regional demand through established pharmaceutical industries and increasing adoption of dietary supplements. Manufacturers are expanding automated encapsulation lines, formulation laboratories, quality-control facilities, and export-oriented production capabilities. China maintains a significant supplier base, while India benefits from extensive pharmaceutical manufacturing expertise and contract production infrastructure. Japan contributes through stringent quality standards and sophisticated consumer health products. Increasing urbanization and healthcare accessibility are strengthening demand for vitamins, minerals, omega oils, botanical formulations, and specialty medicines. Plant-derived shells are also attracting manufacturers targeting vegetarian and clean-label consumers. Regional production expansion provides opportunities for local companies to compete with multinational contract manufacturers. Rising preventive healthcare awareness, expanding digital pharmacies, and broader availability of nutritional products continue to strengthen Asia Pacific's position within the global industry.

• Middle East & Africa

Middle East & Africa accounts for 8% of global demand, supported by improving healthcare infrastructure, increasing pharmaceutical availability, and greater consumer awareness of nutritional supplementation. Gulf countries represent important commercial centers because modern pharmacy networks and healthcare systems provide broad access to vitamins, minerals, prescription products, and wellness formulations. South Africa also contributes through established pharmaceutical distribution and supplement retail channels. Demand is particularly visible for vitamin D, omega oils, multivitamins, botanical ingredients, and other formulations suited to liquid-filled dosage technologies. International manufacturers and regional distributors are strengthening supply networks to improve product availability across major urban markets. Local pharmaceutical companies are additionally evaluating contract manufacturing and private-label strategies to broaden product portfolios without establishing specialized encapsulation facilities. Vegetarian formulations offer another opportunity because ingredient sourcing and dietary considerations influence purchasing behavior among selected consumer groups. Increasing preventive health awareness and expanding modern retail infrastructure are supporting gradual market penetration across the region.

• Rest of the World

Rest of the World represents 7% of global demand, with Latin America providing an important contribution through pharmaceutical manufacturing, contract production, and expanding consumer healthcare distribution. Brazil, Mexico, Colombia, and neighboring markets demonstrate increasing interest in nutritional products and convenient oral dosage forms. Procaps maintains significant manufacturing expertise in Latin America, strengthening regional access to advanced encapsulation and contract development capabilities. Applications include analgesics, vitamins, gastrointestinal medicines, omega formulations, nutritional products, and specialized consumer healthcare solutions. Regional manufacturers increasingly pursue private-label partnerships and technology-based differentiation to compete with multinational suppliers. Growing pharmacy penetration and digital commerce are improving access to nutritional and pharmaceutical products outside major metropolitan centers. Manufacturers are also developing plant-derived formulations and specialized ingredient combinations to address changing consumer preferences. Expanding healthcare coverage, preventive wellness awareness, localized manufacturing, and partnerships between regional businesses and international healthcare companies support continued development across these markets.

KEY INDUSTRY PLAYERS

Competition includes established contract development organizations, pharmaceutical manufacturers, supplement specialists, and regional producers. Catalent and Aenova maintain leading positions through manufacturing scale, formulation capabilities, technical expertise, and international production networks. Procaps, Sirio Pharma, Patheon, Captek, Strides Pharma Science, and Lonza strengthen competition through specialized development platforms and contract manufacturing services. The competitive landscape remains relatively fragmented, with Catalent holding 4.70% share. Companies increasingly differentiate through vegetarian shells, smaller dosage formats, bioavailability technologies, formulation services, and private-label manufacturing. Partnerships with pharmaceutical brands and ingredient developers help producers accelerate commercialization while expanding geographic reach and manufacturing flexibility.

List of Top Softgel Capsules Companies

• Catalent
• Aenova
• Nature’s Bounty
• Procaps
• Patheon (Thermo Fisher Scientific)
• Aland
• EuroCaps
• Captek
• Strides Pharma Science
• Lonza (Capsugel)
• Soft Gel Technologies
• Amway
• Sirio Pharma
• Baihe Biotech
• Ziguang Group
• Shineway
• Donghai Pharm
• By-Health
• Yuwang Group
• Guangdong Yichao

List of Top 2 Companies Market Share

• Catalent: Holds 4.70% share through extensive formulation expertise, global manufacturing capacity, and differentiated delivery technologies.
• Aenova: Commands 4.51% share through large-scale contract manufacturing, technical capabilities, and international production infrastructure.

Investment Analysis and Opportunities

Investment opportunities are increasing across plant-based shell development, automated production, formulation laboratories, specialized contract manufacturing, and advanced oral drug-delivery technologies. Non-animal products represent 37% of the type segmentation used throughout this report, highlighting substantial potential for manufacturers targeting vegetarian and clean-label demand. Investment is also moving toward production flexibility, allowing facilities to process multiple shell materials and ingredient combinations efficiently. Attractive opportunities exist within personalized nutrition, beauty-from-within products, healthy-aging supplements, sports nutrition, and specialty medicines. Emerging Asian manufacturing hubs provide additional expansion potential, while strategic partnerships can help manufacturers strengthen technical capabilities, accelerate commercialization, and improve regional supply resilience.

New Product Development

Product development increasingly emphasizes plant-derived shells, smaller capsules, enhanced ingredient stability, improved swallowing convenience, and specialized release characteristics. Manufacturers are developing dosage systems capable of carrying oils, poorly soluble compounds, vitamins, botanical extracts, and complex nutritional combinations. Gelatin type products retain 63% share within this report, but innovation is increasingly directed toward vegetarian alternatives and flexible production platforms. Companies are also developing chewable formats, modified-release solutions, combination technologies, and personalized nutritional formulations. Advanced encapsulation equipment enables improved sealing consistency and accurate fill control. Future innovation will increasingly focus on bioavailability, clean-label ingredients, sustainable sourcing, consumer convenience, formulation flexibility, and efficient commercial-scale manufacturing.

Softgel Capsules Five Recent Developments (2025–2026)

• January 2025 – Nature’s Bounty Nature’s Bounty expanded plant-based omega supplementation with algae-derived capsule formulations.

Nature’s Bounty introduced algae-derived omega products, expanding vegetarian nutritional options while addressing consumer demand for plant-based cardiovascular, joint, skin, and wellness supplementation.

• March 2025 – Strides Pharma Science Strides advanced specialized manufacturing operations through the OneSource business restructuring initiative.

Strides Pharma Science transferred specialized manufacturing operations into OneSource, creating a focused contract development platform designed to strengthen customer relationships, capabilities, and operational specialization.

• April 2025 – Sirio Pharma Sirio introduced HydraPearls technology targeting advanced nutritional and skin hydration applications.

Sirio Pharma developed HydraPearls formulations combining specialized nutritional ingredients and delivery capabilities, expanding its consumer health portfolio toward hydration, beauty, and functional wellness applications.

• October 2025 – Lonza Lonza expanded plant-based capsule innovation through its Organicaps clean-label delivery platform.

Lonza introduced plant-derived Organicaps technology, strengthening sustainable dosage capabilities while addressing growing demand for organic ingredients, clean-label positioning, and alternative shell solutions.

• March 2026 – Sirio Pharma Sirio expanded lipid-based supplementation capabilities with patented LifeChews delivery technology.

Sirio Pharma introduced plant-based LifeChews for oil-soluble active ingredients, broadening its dosage technology portfolio while targeting improved convenience, dispersibility, formulation flexibility, and compliance.

Softgel Capsules Market Report Coverage

The softgel capsules market report evaluates industry structure, demand patterns, competitive positioning, technological developments, segmentation, regional performance, investment opportunities, and product innovation. Type coverage includes gelatin and non-animal formulations, while applications comprise health supplements, pharmaceuticals, and other specialized uses. Pharmaceutical products account for 60% of the application segmentation maintained throughout the report. Geographic coverage includes North America, Europe, Asia Pacific, Middle East & Africa, and Rest of the World, with regional shares totaling exactly 100%. Competitive assessment covers established multinational manufacturers and emerging producers while examining production capabilities, partnerships, product differentiation, material innovation, contract manufacturing strategies, and evolving customer requirements.